Oxygen linked pyrimidine derivatives
US8153632B2 · kind B2 · utility
2Cited by
0References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 15, 2006 |
| Grant date | Apr 10, 2012 |
| Priority date | — |
| Expiry date | Jan 17, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D515/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to pyrimidine compounds that are useful as anti-proliferative agents. More particularly, the present invention relates to oxygen linked and substituted pyrimidine compounds, methods for their preparation, pharmaceutical compositions containing these compounds and uses of these compounds in the treatment of proliferative disorders. These compounds may be useful as medicaments for the treatment of a number of proliferative disorders including tumors and cancers as well as other disorders or conditions related to or associated with kinases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.